Doctor Yale Mitchel
Rahway (United States of America)
Anacetrapib decreases LDL-C in patients with heterozygous familial hypercholesterolemia irrespective of the underlying genetic mutation
Event: ESC Congress 2017
Topic: Lipids (Epidemiology and Prevention)
Session: Lipids
ESC 365 is supported by
